Galmed Pharmaceuticals
GLMD
#10452
Rank
A$6.3 M
Marketcap
A$1.15
Share price
-2.64%
Change (1 day)
-74.27%
Change (1 year)

Market capitalization of Galmed Pharmaceuticals (GLMD)

Market cap: A$6.3 Million

As of January 2026 Galmed Pharmaceuticals has a market cap of A$6.3 Million. This makes Galmed Pharmaceuticals the world's 10452th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galmed Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$6.3 M-10.86%
2025A$7.07 M-14.86%
2024A$8.31 M210.61%
2023A$2.67 M-85.55%
2022A$18.51 M-70.59%
2021A$62.97 M-26.95%
2020A$86.19 M-50.61%
2019A$0.17 B-14.36%
2018A$0.20 B26.72%
2017A$0.16 B171.82%
2016A$59.15 M-48.98%
2015A$0.11 B47.4%
2014A$78.66 M

End of Day market cap according to different sources

On Jan 15th, 2026 the market cap of Galmed Pharmaceuticals was reported to be:

A$6.41 Million
by Nasdaq info icon info icon
A$6.41 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Catalent
CTLT
A$17.22 B 272,935.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
A$0.21 M-96.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
A$1.12 B 17,757.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Evoke Pharma
EVOK
A$28.32 M 348.96%๐Ÿ‡บ๐Ÿ‡ธ USA